Roger M. Clarnette

8 Verdun St
Nedlands, WA 6009, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Phase 3 randomized clinical trials of simufilam in mild-to-moderate Alzheimer's disease.

Phase 3 randomized clinical trials of simufilam in mild-to-moderate Alzheimer's disease.

Journal: The journal of prevention of Alzheimer's disease

Published: August 19, 2025

Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease.

Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease.

Journal: Acta neuropathologica

Published: February 24, 2025

Deferiprone in Alzheimer Disease: A Randomized Clinical Trial.

Deferiprone in Alzheimer Disease: A Randomized Clinical Trial.

Journal: JAMA neurology

Published: November 04, 2024

Predicting Outcomes in Frail Older Community-Dwellers in Western Australia: Results from the Community Assessment of Risk Screening and Treatment Strategies (CARTS) Programme.

Predicting Outcomes in Frail Older Community-Dwellers in Western Australia: Results from the Community Assessment of Risk Screening and Treatment Strategies (CARTS) Programme.

Journal: Healthcare (Basel, Switzerland)

Published: May 30, 2024

Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical Trials.

Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical Trials.

Journal: The journal of prevention of Alzheimer's disease

Published: May 06, 2024

The AUstralian multidomain Approach to Reduce dementia Risk by prOtecting brain health With lifestyle intervention study (AU-ARROW): A study protocol for a single-blind, multi-site, randomized controlled trial.

The AUstralian multidomain Approach to Reduce dementia Risk by prOtecting brain health With lifestyle intervention study (AU-ARROW): A study protocol for a single-blind, multi-site, randomized controlled trial.

Journal: Alzheimer's & dementia (New York, N. Y.)

Published: December 10, 2023

The therapeutic potential of probucol and probucol analogues in neurodegenerative diseases.

The therapeutic potential of probucol and probucol analogues in neurodegenerative diseases.

Journal: Translational neurodegeneration

Published: November 05, 2023

Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's disease.

Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's disease.

Journal: European journal of nuclear medicine and molecular imaging

Published: December 08, 2022

Balance on the Brain: a randomised controlled trial evaluating the effect of a multimodal exercise programme on physical performance, falls, quality of life and cognition for people with mild cognitive impairment-study protocol.

Balance on the Brain: a randomised controlled trial evaluating the effect of a multimodal exercise programme on physical performance, falls, quality of life and cognition for people with mild cognitive impairment-study protocol.

Journal: BMJ open

Published: April 19, 2022

Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease.

Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease.

Journal: Annals of neurology

Published: March 14, 2022

Efficacy of probucol on cognitive function in Alzheimer's disease: study protocol for a double-blind, placebo-controlled, randomised phase II trial (PIA study).

Efficacy of probucol on cognitive function in Alzheimer's disease: study protocol for a double-blind, placebo-controlled, randomised phase II trial (PIA study).

Journal: BMJ open

Published: February 22, 2022

Early identification of frailty: Developing an international delphi consensus on pre-frailty.

Early identification of frailty: Developing an international delphi consensus on pre-frailty.

Journal: Archives of gerontology and geriatrics

Published: May 24, 2021

Showing 1-12 of 27

Last Updated: 09/26/2026